Goran Micevic MD/PhD

Excited to announce that I will be starting my research group at @YaleMed.
If you are interested in epigenetics and cancer immunology (or know someone interested in these topics), reach out/apply: miceviclab.github.io/postdoc-positi…
Please help spread the word!

We are excited to share a preprint of our latest study regarding targeting #DNMT1 to counteract CD8 T cell exhaustion and improve anti-tumor activity: biorxiv.org/content/10.648…

I am a physician scientist @YaleCancer taking care of patients with #cancer and direct a #melanoma research lab. On September 6, 2025, I am taking the fight against cancer to the streets (on a bicycle).  You can join my fundraising effort here: rideclosertofree.org/participants/3…
Thank you!

May is #MelanomaAwarenessMonth. We are sharing our new review on DNA methylation in melanoma immunotherapy and resistance exploring how to improve immune responses and therapies for patients. #Epigenetics #CancerResearch @MelanomaReAlli #dermtwitter

Only a subset of cancer patients currently respond to checkpoint inhibitors, partly due to an unfavorable tumor microenvironment. In a new Phase IB trial in Head and neck squamous cell carcinomas led by @DrSaraPai @YaleCancer